Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019.
van Santen DK, Sacks-Davis R, Stewart A, Boyd A, Young J, van der Valk M, Smit C, Rauch A, Braun DL, Jarrin I, Berenguer J, Lazarus JV, Lacombe K, Requena MB, Wittkop L, Leleux O, Salmon D, Bonnet F, Matthews G, Doyle JS, Spelman T, Klein MB, Prins M, Asselin J, Stoové MA, Hellard M, InCHEHC study group
"Like a pickle that's been unpickled": Emotional, identity and behavioural transformations throughout hepatitis C treatment.
Goutzamanis S, Doyle JS, Horyniak D, Higgs P, Hellard M
Validation of novel point-of-care test for alanine aminotransferase measurement: A pilot cohort study.
Howell J, Van H, Pham M, Sawhney R, Li F, Bhat P, Lubel J, Kemp W, Bloom S, Majumdar A, McCaughan G, Hall S, Spelman T, Doyle JS, Hellard M, Visvanathan K, Thompson AJ, Drummer HE, Anderson D
Quarantine preparedness - the missing factor in COVID-19 behaviour change? Qualitative insights from Australia.
Davis A, Munari S, Doyle J, Sutton B, Cheng A, Hellard M, Gibbs L
Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort.
Bartlett SR, Verich A, Carson J, Hosseini-Hooshyar S, Read P, Baker D, Post JJ, Finlayson R, Bloch M, Doyle JS, Shaw D, Hellard M, Martinez M, Marks P, Dore GJ, Matthews GV, Applegate T, Martinello M
Constructing a 'target population': A critical analysis of public health discourse on substance use among gay and bisexual men, 2000-2020.
Schroeder SE, Bourne A, Doyle JS, Hellard ME, Stoové M, Pedrana A